// App-Quantinova.ai

: Pancreatic neuroendocrine tumors: a multicenter international evaluation of grading, staging and outcomes

Researchers

Presenter

  • P. Worth

Principal Investigators

  • J. Leal

  • Z. Soonawalla

  • P. Athanasopoulos

  • C. Toumpanakis

  • P. Newell

  • R. Parks

  • B. Lawrence

  • E. Vicente Lopez

  • B. Visser

Medical Centers

  • Department of Pediatrics, Stanford University, Palo Alto, CA, United States,

  • Department of Surgery, University of Edinburgh, United Kingdom

  • HPB Surgery, University of Cambridge and Addenbrooke's Hospital, United Kingdom

  • Department of Surgery, University College London, Royal Free Hospitals, United Kingdom

  • Department of Surgery, Providence Portland Cancer Center, United States

  • Department of Surgery, University of Edinburgh, United Kingdom

  • Department of Surgery, University of Auckland, Auckland, New Zealand

  • Department of Surgery, Hospital Universitario de La Princesa, Madrid, Spain

Locations

  • United States

  • United Kingdom

  • New Zealand

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic Neuroendocrine Tumors

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved